| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |